Article: A Case of Multiple Myeloma in a 17-Year-Old Girl Treated with Autologous Hematopoietic Stem Cell Transplantation (ASCT)

BACKGROUND Multiple myeloma is mainly a disease of the elderly. The diagnosis of multiple myeloma in patients under 30 years of age is rare. A rare case is presented of a 17-year-old girl diagnosed with multiple myeloma who was successfully treated with autologous hematopoietic stem cell transplantation (ASCT). CASE REPORT A 17-year-old Vietnamese girl presented with pain in the left hip and difficulty walking. She was diagnosed with stage IIIA IgG lambda (l) multiple myeloma and was treated with a bortezomib-based chemotherapy regimen followed by ASCT. The patient showed a good response to treatment. At 14-month follow-up, her bone pain had resolved, and her ability to walk was improved. CONCLUSIONS A rare case of multiple myeloma is presented in a 17-year-old girl who responded well to ASCT.

Citing Articles

Case Report: Multiple Vertebral Compression Fractures in 14-Year-Old Children With Multiple Myeloma.

Wang X, He H, Zhang M, Li C, Jia C Front Oncol. 2021; 11:662169.

PMID: 33869065 PMC: 8044764. DOI: 10.3389/fonc.2021.662169.

References

1.

Ishida T, Dorfman H . Plasma cell myeloma in unusually young patients: a report of two cases and review of the literature. Skeletal Radiol. 1995; 24(1):47-51. DOI: 10.1007/BF02425947. View

2.

Ludwig H, Durie B, Bolejack V, Turesson I, Kyle R, Blade J . Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group. Blood. 2008; 111(8):4039-47. PMC: 4259800. DOI: 10.1182/blood-2007-03-081018. View

3.

Rajkumar S . Multiple myeloma: 2014 Update on diagnosis, risk-stratification, and management. Am J Hematol. 2014; 89(10):999-1009. DOI: 10.1002/ajh.23810. View

4.

Kumar S, Rajkumar V, Kyle R, van Duin M, Sonneveld P, Mateos M . Multiple myeloma. Nat Rev Dis Primers. 2017; 3:17046. DOI: 10.1038/nrdp.2017.46. View

5.

Blade J, Kyle R, Greipp P . Multiple myeloma in patients younger than 30 years. Report of 10 cases and review of the literature. Arch Intern Med. 1996; 156(13):1463-8. DOI: 10.1001/archinte.1996.00440120125014. View

6.

Harousseau J, Attal M, Leleu X, Troncy J, Pegourie B, Stoppa A . Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of an IFM phase II study. Haematologica. 2006; 91(11):1498-505. View

7.

Durie B, Salmon S . A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer. 1975; 36(3):842-54. DOI: 10.1002/1097-0142(197509)36:3<842::aid-cncr2820360303>3.0.co;2-u. View

8.

Jurczyszyn A, Davila J, Kortum K, Jayabalan D, Vij R, Fiala M . Multiple myeloma in patients up to 30 years of age: a multicenter retrospective study of 52 cases. Leuk Lymphoma. 2018; 60(2):471-476. DOI: 10.1080/10428194.2018.1480766. View

9.

Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

10.

Palumbo A, Avet-Loiseau H, Oliva S, Lokhorst H, Goldschmidt H, Rosinol L . Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group. J Clin Oncol. 2015; 33(26):2863-9. PMC: 4846284. DOI: 10.1200/JCO.2015.61.2267. View